More #WPRDAY2026 Subscribe & Follow Novos expired semaglutide patent fires up weight-loss drug market The South African Health Products Regulatory Authority (SAHPRA) told Reuters that it is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisks blockbuster diabetes and weight-loss medicines
Leonardo Vando, MD is Principal Investigator of Psychiatry at Vando Medical Services.
Can I do it with creams only
Retatrutide is a synthetic triple-agonist peptide that acts on the GIP, GLP-1 and glucagon receptors simultaneously, making it a compound of significant interest in metabolic and receptor-signalling research models
In the fresh material, the concentration of quinoline, all tested iodoquinolines, iodide ions, L-ascorbic acid, dehydroascorbic acid, nitrogen compounds and chlorides was also determined
The American Heart Association has highlighted growing research into how GLP 1 based medicines may reduce cardiovascular risk in people with obesity and cardiovascular disease